Proteomic study for serum biomarkers in Parkinson's disease using weak cation exchange magnetic beads and MALDI-TOF-MS
10.3760/cma.j.issn.1006-7876.2009.02.009
- VernacularTitle:弱阳离子交换纳米磁珠介导的帕金森病血清蛋白质组学的初步研究
- Author:
Jian WANG
;
Yaohua LI
;
Xiaoli ZHENG
;
Yanli ZHANG
;
Xin LI
;
Shun YU
;
Xin HE
;
Biao CHEN
- Publication Type:Journal Article
- Keywords:
Parkinson disease;
Proteomics;
Biological markers;
Ion exchange
- From:
Chinese Journal of Neurology
2009;42(2):98-101
- CountryChina
- Language:Chinese
-
Abstract:
Objective To screen for the potential protein biomarkers in serum for the diagnosis of idiopathic Parkinson's disease (PD) using proteomic fingerprint technology. Methods Proteomic fingerprint technology combining weak cation exchange (WCX) magnetic beads with MALDI-TOF-MS was used to identify and compare the serum proteins from 61 patients with idiopathic PD, 29 patients with other neurodegenerative diseases (OND) and 30 healthy blood donors. Model of biomarkers and proteomics patterns associated with PD was analyzed by Biomarker Patterns Software. The model also was validated by 40 newly recruited PD cases. Results A total of 17 discriminating M/Z peaks which were related to PD were identified ( nonparametric test, Z:-4.039--2.633, P<0.01 ). Five biomarkers with M/Z of 6121, 5234, 2961,4309 and 8170 respectively generated an excellent model of distinguishing between PD and healthy groups. The sensitivity was 98.4% and the specificity was 83.1%. Blind testing in 40 newly recruited cases demonstrated a sensitivity of 85.0% (17 of 20 PD) and a specificity of 70. 0% (14 of 20 controls). Conclusions Combination of WCX magnetic beads with MALDI-TOF-MS is a useful method in establishing proteomic patterns associated with PD. It also may be used to construct a diagnostic model with PD Biomarkers. Although this model of biomarkers fails to distinguish between PD and OND controls, it is able to differentiate PD from healthy controls.
